On the other hand, experimental evidence currently suggests that HDAC1 and HDAC2 can bind to ΔNp63α, a prognostic marker for HNSCC, forming an active transcriptional repressor complex that promotes tumor progression (10). This evidence concerns the gene HDAC1 and head and neck squamous cell carcinoma.